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Proximal tubular epithelial cells are highly energy de-
manding. Their energy need is covered mostly from
mitochondrial fatty acid oxidation. Whether derailments
in fatty acid metabolism and mitochondrial dysfunction
are forerunners of tubular damage has been suggested
but is not entirely clear. Here we modeled mitochondrial
overload by creating mice lacking the enzyme carnitine
acetyltransferase (CrAT) in the proximal tubules, thus
limiting a primary mechanism to export carbons under
conditions of substrate excess. Mice developed tubular
disease and, interestingly, secondary glomerulosclerosis.
This was accompanied by increased levels of apoptosis
regulator andfibrosismarkers, increasedoxidative stress,
and abnormal profiles of acylcarnitines and organic acids
suggesting profound impairments in all major forms of
nutrient metabolism. When mice with CrAT deletion were
fed a high-fat diet, kidney disease was more severe and
developed faster. Primary proximal tubular cells isolated
from the knockout mice displayed energy deficit and
impaired respiration before the onset of pathology, sug-
gesting mitochondrial respiratory abnormalities as a po-
tential underlying mechanism. Our findings support the
hypothesis that derailments of mitochondrial energy me-
tabolismmay be causative to chronic kidney disease. Our
results also suggest that tubular injury may be a primary
event followed by secondary glomerulosclerosis, raising
the possibility that focusing on normalizing tubular cell
mitochondrial function and energy balance could be an
important preventative strategy.
Although there is no doubt that glomerular disease is
a major feature in the development of both diabetic
nephropathy (DN) and obesity-related chronic kidney
disease (CKD), evidence now also indicates proximal tu-
bular injury as an important early event in kidney disease
(1–3). Proximal tubular epithelial cells (PTCs) are highly
energy demanding and contain a large number of mito-
chondria. Their high energy need is primarily covered from
mitochondrial fatty acid oxidation to produce ATP (4–6).
Excess fatty acid metabolites can be shuttled to cytoplas-
mic lipid droplets to shield from toxicity, but this buffer
capacity is limited in PTCs (7,8). Therefore, disturbances in
fatty acid oxidation appear to cause PTC atrophy through
apoptosis (9–15). In type 2 diabetes and obesity, persis-
tently elevated triglyceride and free fatty acid levels in the
circulation (16) are damaging to tubular cells (17,18).
Recent discoveries show that metabolic alterations in
tissues affected by diabetic complications are tissue spe-
cific, with increased fatty acid metabolism in the kidney of
mice and humans with type 2 diabetes (19). Increased
b-oxidation, however, is not matched with ATP production.
The kidney cortex (;90% tubular cells) shows accumula-
tion of intermediate metabolic products from mitochon-
drial b-oxidation. After an initial increase, tricarboxylic
acid (TCA) cycle activity slows in advanced kidney disease,
and organic acid metabolites from the TCA cycle are lost
into the urine. These conditions altogether are consistent
with “mitochondrial lipid overload” (20–24).
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Mitochondrial overload is not a new phenomenon, but
its contribution to CKD is not known. It was first described
in skeletal muscle in the context of insulin resistance (22),
where mitochondria are presented with substrate excess.
This substrate excess overwhelms the catabolic capacity of
mitochondrial b-oxidation. Consequently, free CoA levels
decline as increased supply and oxidation of fatty acids
leads to accumulation of excess acetyl-CoA. Mitochondrial
overload also results in increased levels of incompletely
oxidized products: long- and medium-chain acylcarnitines
and acyl-CoAs. Sustained elevation in incomplete fatty acid
oxidation then may foster a mitochondrial microenviron-
ment conducive to oxidant stress (25). This is because
a chronic increase in substrate entry to the mitochondria
produces reducing equivalents in excess of that which can
be handled by the electron transport chain (ETC). This
leads to increased NADH and FADH2 (reduced form of
flavin adenine dinucleotide) levels. Such an increase was
proposed to induce electron “backpressure” and reactive
oxygen species (ROS) production.
To model this mitochondrial substrate overload, we
ablated the enzyme carnitine acetyltransferase (CrAT) in
proximal tubular epithelial cells in mice (PT-CrAT mice).
CrAT is a mitochondrial matrix enzyme, serving as a “relief
valve” (26). It facilitates the export of excess, preferably
short-chain acyl-CoA products out of the mitochondria by
linking them to carnitine, making these products mem-
brane permeable (23). Because acylcarnitines can traverse
membranes, CrAT also plays a key role in regulating cellular/
mitochondrial acetyl- and acyl-CoA balance and carbon traf-
ficking. In the absence of CrAT, the acetyl-CoA–to–CoA ratio
increases, and some partially oxidized products cannot exit the
mitochondria. CrAT deletion therefore leads to the accumu-
lation of incompletely oxidized acyl-CoA products and mito-
chondrial acetyl-CoA overload (22,27).
Our goal in the current study was to understand
whether such conditions can be the forerunners of tubular
disease. We demonstrate that PT-CrAT mice develop not
only tubular but also glomerular disease and that a high-fat
diet (HFD) exacerbates pathology. We also provide evi-
dence that impaired mitochondrial respiration in over-
loaded PTCs precedes the onset of disease development.
Thus, our data indicate that PTC-specific deletion of CrAT
causes kidney disease and that mitochondrial overload
promotes the acceleration of CKD in relation to metabolic
disease.
RESEARCH DESIGN AND METHODS
All animal studies were performed at the Association for
Assessment and Accreditation of Laboratory Animal Care
International–accredited facility of Pennington Biomedical
Research Center and approved by the Institutional Animal
Care and Use Committee.
Animals
Mice with targeted deletion of CrAT in the PTC were
generated using the Cre-loxP recombination strategy
(Fig. 1). Homozygous CrATloxP female mice (C57BL/6J)
were bred to male g-glutamyl transferase Cre mice (Tg-
(Ggt1-cre)M3Egn/J, mixed Balb/cJ/C57BL/6 background;
The Jackson Laboratory). Offspring heterozygous to CrAT-
loxP were backcrossed to the CrATloxP mice. This cross
produced offspring of which 50% were PTC-specific CrAT
ablated (PT-CrAT) mice. Littermate homozygous fl/fl, Cre-
negative mice were used as controls. To verify the regions
of the kidney with Cre-recombinase activity, a set of
PT-CrAT female mice were bread with a “tdTomato”
(B6.Cg-Gt(ROSA)26Sor,tm14(CAG-tdTomato)Hze./J)
male.
Kidneys of the Cre-positive offspring were dissected at
4 weeks of age, sectioned, and photographed under a Leica
DM6000 fluorescent microscope. Another set of kidneys
from fl/fl control and PT-CrAT mice (n = 4/genotype) were
harvested. One kidney per mouse was cryosectioned and
stained with an anti–active-Cre antibody (1:100) (Nova-
gen). Sections were photographed as described above. The
other kidney as well as heart, skeletal muscle, and epidid-
ymal white adipose tissue were used for quantitative (q)
PCR and Western blot analyses to determine CrAT mRNA
expression and protein levels. CrAT activity from kidney
homogenates was measured as previously described (23).
Genotyping was performed on tail DNA using standard
PCR reagents.
Mice were kept in a room with a 12/12-h light/dark
cycle and had access to food and water ad libitum. Mice
were randomly divided into cohorts and fed a chow diet
(5001 Purina Rodent Chow) for 6, 12, 15, 18, and
24 months. Other cohorts were fed a low-fat diet (LFD)
(10% kcal fat from lard) (D12450B; Research Diets) or an
HFD (60% kcal fat from lard) (D12492) up to 18 months.
At the end of each time point, mice were placed in
a metabolic chamber for a 24-h acclimation. Urine was
collected every 24 h, and the 72-h urine was used for
proteinuria analysis and mass spectrometry. Fasting blood
glucose levels were measured from a drop of blood from
the tail vein (OneTouch). For glucose tolerance test, mice
received a dose of 10% glucose solution (200 mL/50 g body
wt, i.p.), and blood glucose levels were measured at 30, 60,
90, and 120 min. Kidneys were excised and halved. One
kidney was fixed in 4% paraformaldehyde and processed
for paraffin embedding, and the other kidney was pro-
cessed in optimal cutting temperature media for cryocut-
ting and immunofluorescent staining.
Histology
Paraffin-embedded kidneys were cut into 5-mm cross
sections. Sections were mounted on charged Superfrost
slides (Fisher Scientific) and deparaffinized. Sections were
stained with 1) periodic acid–Schiff (PAS) to evaluate
glomerular size, sclerosis, and proteinaceous casts and
with 2) trichrome for fibrosis and collagen deposits. At
least 10 viewing areas per slide were evaluated on each
section with a NanoZoomer Digital Pathology Virtual Slide
Viewer.
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Immunostaining
Deparaffinized kidney sections were mounted on Super-
frost slides, permeabilized with 0.1% Triton-X, and blocked
with 1% BSA. Antibodies were diluted in PBS and applied
on kidney sections using a PAP Pen to create a hydrophobic
barrier: rabbit anti-collagen IV, 1:250 (Abcam); mouse
anti-vimentin, 1:250 (Sigma-Aldrich); cleaved caspase-3,
1:200 (Abcam); Lotus tetragonolobus anti-lectin conjugated
with green fluorophore (488 nm), 1:200 (Vector Labora-
tories); and corresponding Alexa Fluor 598 red anti-mouse
or Alexa Fluor 647 cyan anti-rabbit secondary antibodies,
1:750 (Thermo Fisher). Slides were coverslipped (Fluoro-
mount-G) and observed using a Leica DM6000 fluorescent
microscope.
Western Blotting
Kidney cortices were homogenized in lysis buffer and
normalized for protein concentration. Proteins were sep-
arated using gel electrophoresis, transferred onto a nitro-
cellulose membrane, and analyzed by standard Western
blotting methods using the following antibodies: rabbit
anti-CrAT, 1:250 (Proteintech); mouse anti–4-hydroxyno-
nenal (4-HNE), 1:500 (R&D Systems); mouse anti–acetyl-
lysine, 1:500 (Cytoskeleton); mouse anti-OxPhos cocktail,
1:500 (Thermo Fisher); and mouse anti–b-actin or tubulin
as loading control when applicable, 1:5,000. Secondary
antibodies (anti-mouse or anti-rabbit, 1:5,000; conjugated
with horseradish peroxidase) (Thermo Fisher) were ap-
plied at room temperature for 1 h. Band intensities were
measured using the ImageJ software Gel Analysis plug-in.
Primary Cell Culture and Mitochondrial Respiration
Analysis
Kidneys from younger PT-CrAT and fl/flmice (,9 months)
were harvested and placed into ice-cold Krebs-Henseleit
buffer for primary proximal tubular epithelial cell isolation.
PTCs were isolated using a collagenase digestion/sieve/Per-
coll gradient centrifugation method originally described by
Vinay et al. (28). Cells were grown in hormonally defined
DMEM media (28). Once cells reached near confluency
(;day 7–8), they were plated onto 24-well Seahorse
XF24 culture plates (75,000 cells/well). Mitochondrial oxygen
Figure 1—Generation of PTC-specific CrAT knockout mouse and baseline whole-body parameters. A: Genetic strategy to generate mice
with PTC-specific ablation of CrAT (PT-CrAT mouse). B: Deletion was confirmed by PCR in tail DNA. C: CrAT knockout kidney cortices, but
not heart, skeletal muscle, or epididymal white adipose tissue (eWAT), showed a ;2.6-fold reduced expression of CrAT mRNA (n = 6). *P,
0.006, Gapdh reference gene. D: Western blot analysis of CrAT protein levels in kidney cortices showed successful deletion in the PT-CrAT
mice. Kidney and skeletal muscle tissues from mice overexpressing CrAT under the b-actin promoter (BAP-CrAT) were used as positive
control. E: Enzyme activity was measured in whole-kidney homogenates (residual CrAT activity derives from cells other than PTCs). PTC-
specificity was verified by staining for CRE activity with an anti-Cre antibody (F ) and by breeding PT-CrAT female mice with a tdTomato
male (G). Red fluorescence around green brush borders stained positive by Lotus tetragonolobus lectin confirms PTC-specific Cre activity.
Scale bars = 50 mm. PT-CrAT mice body weights (H), kidney weights (I), fasting blood glucose levels (J), and glucose tolerance test (K)
(males, n = 6–8).
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consumption was measured in cells respirating on 5 mmol/L
pyruvate using a Seahorse XF24 Extracellular Flux Analyzer.
Mitochondrial Complex Activities
Complex I and complex V activity was measured from
repeatedly freeze-thawed kidney cortex homogenates by
following the oxidation of NADH at 340 nm. For complex I
activity, the final reaction mixture contained 62.5 mmol/L
ubiquinone, 0.25% BSA, 2 mg/mL antimycin A in 25
mmol/L potassium phosphate buffer (pH = 7.2), and
the sample equivalent to 10 mg protein. Oxidation of
NADHwas followed at 340 nm in the absence and presence
of 10 mg/mL rotenone (3 min each). For complex V
activity, the mixture contained the sample equivalent to
5 mg protein, 10 mL of 30 mmol/L NADH, 50 mL of
50 mmol/L phosphoenolpyruvic acid, 5 mL of 10 mg/mL
pyruvate kinase, 10 mL of 5 mg/mL lactate dehydrogenase,
and 10 mL antimycin A in 900 mL HEPES-Mg2+ buffer
(pH = 8.0) at 30°C. Baseline was recorded for 2 min, then
100 mL of 25 mmol/L ATP was added and the absorbance
recorded for another 2 min. Then 10 mL of 0.2 mg/mL
oligomycin was added and the absorbance was recorded
again for 2 min. In both cases, Vmax values were calculated
from the kinetic graphs, and activities were expressed as
control percentage.
Mass Spectrometry
Kidney cortex, plasma, and urinary levels of acylcarnitines
and organic acids were measured using flow injection
tandem mass spectrometry (MS/MS) at the Duke-National
University of Singapore (29,30).
Electron Paramagnetic Resonance Spectroscopy
A cohort of mice received the spin trap POBN (a-[4-pyridyl
N-oxide]-N-tert-butylnitrone) (500 mg/kg i.p.) 45 min be-
fore euthanasia to analyze lipid-derived free radical pro-
duction. Kidney samples were extracted using a Folch
extraction method (31,32). Extracts were analyzed in
a quartz flat cell using an X-band EMXplus EPR Spectro-
scope (parameters: 3,480 6 80 G scan width, 105 receiver
gain, and 20 mW microwave power; time constant:
1,310 ms; conversion time: 655 ms).
Quantitative PCR
Total RNA from kidney cortices was used for real-time
quantitative (q)PCR to compare gene expressions (Vim,
Col4A1, Col3A1a, Fn, Bax, and Casp-3) between groups
using SYBR Green Master Mix as described by the man-
ufacturer (Applied Biosystems). Fold changes in gene
expression were calculated using the DDCT method.
Albumin and Creatinine
Urinary albumin levels from 24-h urine samples were
measured using the Albuwell M albumin kit (Exocell).
Creatinine levels in serum and urine were measured
using the Creatinine Companion kit (Exocell). Albuminuria
was expressed as albumin-to-creatinine ratios (mg/mg)
according to the Animal Models of Diabetic Complications
Consortium recommendation.
Statistical Analysis
Data are expressed as mean 6 SD. Statistical significances
between fl/fl and PT-CrAT mice or PT-CrAT mice on LFD
versus PT-CrAT mice fed the HFD were determined by
unpaired Student t test.
RESULTS
PT-CrATMice Develop Tubular Disease and Secondary
Glomerulosclerosis
Mice with PTC-specific deletion of CrAT were created using
a Cre-loxP strategy, genotyped, and characterized as de-
tailed in Fig. 1. CrAT deletion was specific to the proximal
tubules (Fig. 1B–G). The first cohorts of mice were fed the
chow diet, and for consistent development of nephropathy
(33), were aged to.12months. Renal tissue was examined
every 3 months. PT-CrAT mice had normal body weights
(Fig. 1H), kidney weights (Fig. 1I), fasting blood glucose
levels (Fig. 1J), and glucose tolerance (Fig. 1K). They
developed tubular disease with protein casts, tubular di-
lation, and fibrosis at ;18–20 months of age (Fig. 2B and
C). Increased levels of collagen IV, vimentin, and cleaved
caspase-3 were detected in PT-CrAT mice using immuno-
fluorescent techniques (Fig. 2F–I). By this time, they also
had increased serum creatinine levels and proteinuria (Fig.
2D and E). Consistently with the stainings, significantly
increased expression levels of vimentin, collagen IV, Bax,
and caspase-3 were detected by qPCR, indicating fibrosis
and activation of apoptosis regulators (Fig. 2J). Interest-
ingly and unexpectedly, PT-CrAT mice also developed
glomerulosclerosis. Within a given cohort of mice, tubu-
lar/glomerular disease and proteinuria always varied to an
extent, with some mice having only mild changes and
others having extensive damage. These results indicate
that ablation of CrAT in the PTC leads not only to tubular
disease but also to proteinuric CKD and facilitates tubular
cell/mitochondrial apoptosis.
PT-CrAT Mice Have Altered Acylcarnitine and Organic
Acid Profiles
Next, to determine the extent of mitochondrial overload,
we measured the levels of acylcarnitine products in fl/fl
and PT-CrAT mice plasma, kidney cortex, and urine. Figure
3A–C shows the results of a detailed MS/MS analysis of
major acylcarnitine species. PT-CrAT mice displayed al-
tered acylcarnitine profiles in the kidney cortex and urine
compared with fl/fl littermates. Notably, CrAT deficiency
in the PTC led to a significant decrease in the levels of
acetyl and several other short- and medium-chain acylcar-
nitines. This result is consistent with the hypothesis
of mitochondrial overload: because of the lack of CrAT
in PTCs, efflux capacity is attenuated, and thus, short-
chain acylcarnitine levels are much lower in the cortex
and urine. Interestingly, and also consistent with previ-
ous observations in skeletal muscle (23), many of the
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longer-chain acylcarnitine levels were increased in the
kidney cortex. Furthermore, several of the measured or-
ganic acid levels (citrate, fumarate, malate, lactate, and
pyruvate) were depleted in the PT-CrAT cortex (Fig. 3G).
We also found an approximately twofold increase in
urinary levels of free and total carnitine in the PT-CrAT
mice, although these differences did not reach statistical
significance (Fig. 3D–F). Carnitine loss to the urine sug-
gests that secondary carnitine insufficiency could develop
that may be attributable to PTC injury (34).
Lipid-Derived Free Radical Production Is Increased in
PT-CrAT Mice
Retaining incompletely oxidized acylcarnitine products in
the mitochondria can lead to conditions favorable for
redox imbalance. This is because mitochondrial overload
may produce reducing equivalents (NADH and FADH2) in
excess of that which can be handled by the ETC (22,25).
Such excess in turn is predicted to create an environment
conducive to oxidative stress. Excess ROS in a membrane-
rich environment, such as the mitochondrial inner mem-
brane, then would increase the odds for lipid peroxidation
(35–37). To address this scenario, we used electron spin
resonance spectroscopy and in vivo spin trapping to
measure the levels of lipid-derived free radicals in kidney
cortices. Results were also confirmed by Western blot
analysis of 4-HNE adducts. Figure 4A shows spectra
obtained from fl/fl and PT-CrAT mouse kidney cortex
extracts. PT-CrAT kidney cortices display an approxi-
mately threefold increase in carbon-centered lipid-derived
Figure 2—CrAT deletion in PTCs causes kidney disease. A: Representative photomicrographs of PAS and trichrome staining in fixed,
paraffin-embedded fl/fl kidneys showing normal histology. B: PT-CrAT kidneys show numerous protein casts in tubular lumen, tubular
dilation (*), lipid droplets in tubular cells, trichrome-positive material/fibrosis (yellow arrows), and secondary glomerular disease ($)
($18 months). C: Tubular injury area was evaluated semiquantitatively, and scores are expressed as minimal 1: ,5% of cortex, mild 2:
5–24%, moderate 3: 25–49%, and severe 4:.50% of cortex (n = 6). **P, 0.005. D: Serum creatinine levels in fl/fl and PT-CrAT mice (n = 4–
10). *P , 0.05. E: Urine protein analysis by electrophoresis/Coomassie blue staining (arrow points at albumin, ;67 kDa) in PT-CrAT mice
compared with fl/fl controls, with equal amounts of protein (20 mg) loaded and urinary albumin-to-creatinine ratios (ACR) (males, n = 8–12).
**P, 0.005. Staining positive for collagen IV (cyan: collagen IV, blue: DAPI) (F ) and vimentin (red: vimentin, blue: DAPI) (G) in PT-CrAT tubules
and glomeruli. (Photomicrographs are frommicewith the highest tubular injury scores.)H: Active caspase-3 staining (red: cleaved caspase-3,
green: Lotus tetragonolobus) in fl/fl and PT-CrAT kidneys. Scale bars = 50 mm. I: Percentage of apoptotic PTCs was evaluated by counting
cleaved caspase-3–positive, Lotus tetragonolobus counterstained cells (n = 4). *P , 0.05. J: Gene expression analysis in fl/fl and PT-CrAT
kidney cortices (n = 6, male mice). *P , 0.05, #P , 0.01, &P , 0.0005 vs. fl/fl.
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free radical production compared with fl/fl littermates.
We consistently found a significant increase of 4-HNE
adducts in CrAT-ablated cortices (Fig. 4B and C). These
results confirm that mitochondrial overload may increase
ROS production, which then also triggers excess lipid
peroxidation.
HFD Challenge Accelerates Kidney Disease in PT-CrAT
Mice
Next, we asked whether obesity and prediabetes-induced
renal injury are accelerated by mitochondrial overload.
We used the HFD challenge to determine whether PT-
CrAT mice are more susceptible to HFD-induced renal
disease. HFD feeding led to an earlier manifestation (12–
15 months) of CKD in the PT-CrAT model (Fig. 5A–C).
Compared with fl/fl littermates fed the HFD or with
PT-CrAT mice fed the LFD, PT-CrAT mice fed the HFD
had larger glomeruli (Fig. 5D) and increased expression
of fibrosis genes Vim, Fn, and Col3A1a (Fig. 5E). Sys-
temic changes, such as body weights, plasma triglyceride,
and free fatty acid levels, however, were compara-
ble between PT-CrAT colonies, regardless of the diet
(Fig. 5F–H). Thus, CrAT deletion in the PTC promotes
obesity/prediabetes-related kidney disease and, potentially
through secondary mechanisms, affects glomerular
structure.
Primary PTCs From PT-CrAT Mice Have Energy Deficit
and Impaired Mitochondrial Respiration
To further assess mechanistic details related to mitochon-
drial overload, we isolated primary PTCs from fl/fl and
PT-CrAT mice. PTCs were isolated from younger mice (up
to 9 months) where pathology was not yet present. When
mitochondrial oxygen consumption rates were compared
in an XF24 Analyzer, cells from the PT-CrAT mice dis-
played significantly lower basal, ATP-linked, and maximal
respiration (Fig. 6A and B). These results indicate early
changes in mitochondrial respiratory function and energy
deficit (lower ATP-linked respiration) in PTCs with mito-
chondrial overload. Importantly, because these alterations
Figure 3—Altered acylcarnitine and organic acid profiles in the PT-CrAT model. Kidney cortex (A), plasma (B), and urine samples (C) from
PT-CrAT mice and fl/fl controls at 18–24 months of age were analyzed by MS/MS for short- (SCAC), medium- (MCAC), and long-chain
acylcarnitines (LCAC), as well as free (D) and total carnitine levels (E). MS/MS analysis was normalized to show mice with the strongest kidney
injury histology scores. F: Free-to-total carnitine ratios indicating urinary wasting of free carnitine are shown. G: Kidney cortices were
analyzed for organic acid intermediates. a-ketogl., a-ketoglutarate. *P , 0.05, **P , 0.005 vs. fl/fl.
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are present before pathology develops in the PT-CrAT
mice, mitochondrial dysfunction and energy deficit could
be a primary cause of tubular cell death later. Tissue
abundance of mitochondrial ETC complexes or the amount
of total acetyl-lysine modified proteins were not differ-
ent between groups (Fig. 6C and D), indicating similar
mitochondrial content in control and CrAT-ablated mice.
However, complex I and complex V activities were im-
paired (Fig. 6E).
DISCUSSION
Mitochondrial overload was first described in skeletal muscle
in relation to the development of insulin resistance (22,25).
The effects of CrAT deletion were also demonstrated first
Figure 3—Continued.
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in skeletal muscle, with many of the results resembling
a scenario that models one specific aspect of obesity or
metabolic disease: overabundance of substrates to the
mitochondria (23). In relation to DN and CKD, there is
limited information available on carbon trafficking, sub-
strate overabundance, and the effects of dysfunction of
mitochondrial enzymes regulating such functions in the
kidney. PTCs rely heavily on mitochondrial fatty acid
oxidation for their energy needs (6), but how deviations
in fatty acid oxidation affect the tubules is not entirely
clear.
Our previous work in cell culture showed that mito-
chondrial entry of fatty acids is required for PTC apoptosis
rather than just cytoplasmic lipid accumulation (38). Here,
we provide evidence that when cellular/mitochondrial acyl-
CoA balance and thus mitochondrial carbon trafficking is
disturbed, mice develop kidney disease. Pathological fea-
tures included tubular dilation, proteinaceous casts, fibro-
sis, proteinuria, and, interestingly, enlarged glomeruli and
copious amounts of glomerular scarring. Importantly,
these changes can be attributed to the tubular deletion
of CrAT and are likely not caused by other whole-body
metabolic alterations because mice display normal body
weight and fasting glucose and respond normally on the
glucose tolerance test. Thus, our results indicate that
a specificmetabolic defect, driven by the deletion of a single
gene of an important metabolic enzyme in PTC mitochon-
dria, is sufficient to cause tubular disease. PT-CrAT mice
recapitulate many features of metabolic disease–related
nephropathies, but without the confounding factors de-
riving from changes in whole-body metabolism during
diabetes. Therefore, it is a useful model to exclusively
study the effects of mitochondrial derailments and sub-
strate overload, without a number of additional factors
that would derive from a diabetes model. Notably,
PT-CrAT mice presented some range in the severity of
pathology. This cannot fully be attributed to the genetic
background because mice were created on the C57BL/6
background, and the original Ggt-Cre mice (mixed
Balb/cJ/C57BL background) were crossed into the C57BL/6
background for generations during the development
and breeding of the cohorts. It is, however, consistent
with previous findings from other mouse models of renal
disease or human nephropathies where varying degrees
of phenotypic changes are a characteristic feature
(39–42).
Our results are in good agreement with those obtained
by skeletal muscle–specific crat deletion. Many of the
short-chain acylcarnitines were present in significantly
lower concentrations in the cortex and urine, with a con-
comitant increase of several of the medium- to long-chain
acylcarnitines. The reduction in the levels of the short-
chain acylcarnitines was more striking than initially
expected. These results suggest that CrAT in the PTC is
absolutely essential to maintain the levels of these metab-
olites. Reduction in the levels of some of the odd-chain
metabolites (C3 and C5, in particular) reveals a more global
effect on substrate metabolism, because these acylcarni-
tines are derived primarily from branched-chain amino
acid metabolism. Plasma levels of most of the acylcarni-
tines examined were not altered significantly, indicating
that other tissues (such as skeletal muscle) are more likely
significant contributors of circulating acylcarnitine levels.
In healthy individuals, carnitine esters are excreted into
the urine. Impairments in acylcarnitine excretion occur
with deteriorating renal function (43). Thus, our findings
of altered acylcarnitine profiles in the PT-CrAT mice may
also suggest slowly declining renal function when PTC
mitochondrial carbon trafficking is disturbed. There is
also resemblance to a type 2 diabetic muscle. In patients
with type 2 diabetes, CrAT mRNA abundance is ;80%
lower in skeletal muscle compared with healthy individuals
(23). In diabetic rats, accumulation of long-chain acylcar-
nitines was accompanied by lower free carnitine levels
Figure 4—PT-CrAT mice have increased lipid-derived free radical levels. A: Representative spectra of POBN-lipid radical adducts detected
by electron spin resonance spectroscopy from Folch extracts of kidney cortex of PT-CrAT mice and fl/fl littermates (n = 5). Increases in the
amplitude of the six line spectrum peaks (arrows) are proportional to an increase in carbon-centered lipid-derived free radical levels. Spectra
show an approximately threefold increase of lipid radicals in the PT-CrAT mice vs. fl/fl control. a.u., arbitrary units. B: Western blot analysis
detected 4-HNE protein adducts. C: Band intensities (normalized to b-actin as loading control) were measured using ImageJ (n = 4). *P, 0.05
vs. fl/fl.
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(44). Carnitine loss to the urine in our model thus suggests
that there may be lower free carnitine levels in the kidney
or that there is carnitine loss due to an increase in injured
PTCs in the PT-CrAT mice. Accumulation of long-chain
intermediates was coupled with depletion of several of the
organic (TCA) intermediates. This observation is consis-
tent with earlier ones in different organs where heightened
b-oxidation appeared to reduce the levels of TCA inter-
mediates (22). Such results may reflect compromised
mitochondrial status. Markedly reduced pyruvate and
lactate levels also suggest impairments in carbohydrate
metabolism.
Susztak and colleagues (10) studied derailments in fatty
acid oxidation, focusing on the mitochondrial fatty acid
import side. Their studies demonstrated lower expression
of carnitine palmitoyltransferase (Cpt1a) in kidneys from
DN patients or in mice with tubulointerstitial fibrosis.
Cpt1 facilitates the import of long-chain fatty acyl-CoAs
into the mitochondria for b-oxidation (45,46). Defects in
fatty acid oxidation caused by downregulation or inactivity
of Cpt1 are detrimental to the tubules. In light of the data
of the Susztak group and ours, it seems that not only
defective mitochondrial fatty acid oxidation but also a fail-
ure to remove excess acetyl-CoA and acylcarnitine prod-
ucts promotes kidney disease. Because acetyl-CoA is
a central metabolic intermediate, acetyl-CoA–to–CoA im-
balance in the PTC appears to affect all three major
nutrient metabolism pathways. Because the glycolytic
ability of the PTC is not significant and thus “substrate
switching”—unlike in skeletal muscle—is not prominent
Figure 5—The HFD accelerated kidney disease in the PT-CrAT mice. Representative photomicrographs of PAS- and trichrome-stained
kidneys of littermate fl/fl mice showing normal histology (A), fl/fl mice fed the HFD (B), and PT-CrAT mice fed the HFD (C) showing tubular
damage (*), fibrosis, and trichrome-positivematerial (yellow arrows), as well as glomerular sclerosis ($) and glomerulomegalia (12–15months).
D: Glomerular tuft size wasmeasured in each group (n = 30–50 glomeruli per group, at 12 months of age). Gene expression analysis in kidney
cortices (E), body weights (F ), plasma triglyceride (G), and free fatty acid levels (H) in each experimental group (n = 4–6). #P, 0.05 vs. fl/fl on
chow diet, *P , 0.05 vs. PT-CrAT on chow diet.
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in the tubules, we propose that PTCs can handle an
abundance of lipid-based substrates as long as the mito-
chondrial influx or efflux capacity of substrates/products is
not compromised. Cpt1 and CrAT deficiencies both seem
to accompany the development of type 2 diabetes and
could therefore be significant contributors to tubular
damage in CKD/DN.
Regarding ROS production, a prevailing theory is that
acetyl-CoA is the main fuel for the TCA cycle but that an
overabundance of acetyl-CoA will produce reducing equiv-
alents (NADH and FADH2) in excess of what can be
handled by the ETC (22,25). This excess in turn creates
an environment conducive to oxidative stress through the
“backflow” of electrons from complex III toward complex I
(25,47). Such redox pressure may exist regardless of
whether TCA activity is increased (early diabetic kidney
disease) or decreased (late diabetic kidney disease) (19)
because heightened b-oxidation will provide excess NADH
and FADH2. The “backflow” can change the reduced/
oxidized state of the ETC complexes, leading to slower
or diminished ATP production as a potential mechanism
contributing to PTCs’ energy deficit. Our data confirm
that CrAT ablation increases the steady-state levels of
lipid peroxide radicals as well as their end products,
4-HNE, in kidney cortex. Our results also suggest that
in a lipid-rich environment such as the mitochondria, with
ROS production sites close to membrane structures, the
odds are increased for lipid radical production and lipid
peroxidation.
This may not, however, be the only mechanism con-
tributing to cell damage or may only be limited to the
mitochondria. Excess acetyl-CoA can also drive acetylation
of proteins, particularly the proteins of the ETC. In this
regard, lysine acetylation of mitochondrial proteins has
been gaining attention as a prominent posttranslational
modification causing cellular stress, where the buffering
capacity of CrAT was highlighted (47). Modification of
ETC proteins could then cause a slowdown in ATP pro-
duction. Although there were no detectable differences in
the levels of Lys acetylated proteins between control and
Figure 6—Primary PTCs from PT-CrATmice have early alterations inmitochondrial respiratory function. PTCs isolated from fl/fl and PT-CrAT
mouse kidneys (9 months) were grown on Seahorse XF24 plates (75,000 cells/well). A: Mitochondrial oxygen consumption rates (OCR) were
measured at baseline and after the addition of 2 mmol/L oligomycin, 2 mmol/L FCCP, or 1.5 mg/mL antimycin A (AA). B: Mitochondrial
respiratory parameters were calculated and compared from the graph shown on A (n = 10). *P, 0.05 vs. fl/fl. Total acetylated lysine (Acetyl-
Lys) levels (C), abundance of mitochondrial ETC complexes (D), and activity of mitochondrial complex I and V in kidney cortices of fl/fl and
PT-CrAT mice (n = 4) (E). a.u., arbitrary units. *P , 0.05 vs. fl/fl.
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CrAT-ablated mice in kidney cortex homogenates (Fig.
6C), acetylation as a posttranslational modification is
still worthy of further investigation. Detailed analysis in
isolated mitochondria or challenging permeabilized mito-
chondria with acetyl-CoA + carnitine addition may reveal
differences in howmitochondrial overload can trigger such
modifications.
Our data also reveal mitochondrial energy deficit and
respiratory impairments as a potential mechanism leading
to tubular injury, because these alterations are present
before the onset of significant pathology. Primary PTCs
isolated from the PT-CrAT mice at;9 months of age grew
well in hormonally defined DMEM. At the same cell
density, however, their mitochondrial respiration was
significantly lower than those isolated from littermate
fl/fl mice (Fig. 6). Most importantly, PTCs from PT-
CrAT mice displayed energy deficit and lower ATP-linked
respiration, suggesting that indeed, tubular mitochondrial
acetyl-CoA imbalance leads to derailments in mitochon-
drial energy production. If PTC mitochondria are not
able to meet the energy need of tubular cells, this could
lead to significant deficits in, for example, tubular epithe-
lial function such as Na+/K+ ATPase activity. It is note-
worthy that we only tested these primary cells respirating
on pyruvate; therefore, we cannot conclude whether
PTCs lacking CrAT would respirate differently on other
substrates such as, for example, succinate or glutamate/
malate. As it has been proposed before that excess acetyl-
CoA is able to block PDH activity (23), a possible in-
terpretation of our result is that PTCs with CrAT ablation
cannot efficiently catabolize pyruvate. Mitochondrial con-
tent and abundance of ETC complexes was not different
between normal and CrAT-ablated mice; however, activ-
ities of complex I and complex V were reduced. It is
therefore likely that functionality or oxidized/reduced
state of such complexes and/or one or more of their
subunits are altered. Further investigation into mitochon-
drial structure, pathways, and function is warranted,
which was ongoing in our laboratory at the time this
report was finalized. This includes electron microscopy
analysis of mitochondrial structure, functional analysis of
PT-CrAT tubular cells, and a detailed next-generation
sequencing analysis of PT-CrAT cortices along a full time-
line from 3 to 24 months to understand causality.
Our findings about secondary glomerulosclerosis are
puzzling. Because CrAT has only been deleted in the
proximal tubules, we suspect this is an indirect effect
resulting from initial tubular damage. Also noteworthy
is that regardless of the variability of the phenotype (mild
to more severe in the PTC), we consistently found sec-
ondary sclerosis in all of our cohorts. Similar findings have
been reported before. Bonventre and colleagues (48) found
Figure 7—A proposed scenario of mitochondrial overload in PTCs. Mitochondrial overload modeled by CrAT deletion causes acetyl-CoA/
free CoA imbalance and leads to the accumulation of incompletely oxidized products. Such imbalance affects all three major metabolic
pathways in PTCs: fatty acid, amino acid, and carbohydrate metabolism. As shown by our mass spectrometry results, overload also affects
TCA cyclemetabolite levels. Altogether, thesemetabolic disturbances can contribute to PTC energy deficit. Furthermore, overload can cause
mitochondrial redox imbalance through affecting the ETC. Increased ROS and lipid peroxide production then also potentially contributes to
PTC apoptosis.
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that repeated, selective tubular epithelial injury led to
secondary glomerulosclerosis. The authors surmised that
this effect could be attributed to a paracrine signaling
mechanism derived from injured/regenerating epithelium
or to a reduction of glomerular blood flow as a result of
decreased loss of capillaries in tubulointerstitial fibrosis. It
is also possible that a progressive tubulointerstitial re-
action may directly encroach upon the glomerular tuft,
causing the narrowing and disconnection of the glomer-
ulotubular junction (49–51). These results warrant further
studies to determine the exact cause of glomerulosclerosis
observed in the PT-CrAT model.
CrAT deletion also further sensitized mice to HFD-
induced renal injury. We surmise that this is because excess
substrate caused by the chronic lipid exposure further
compromises mitochondrial acetylcarnitine and short-
chain acylcarnitine efflux capacity. These metabolites,
together with a further surplus of reducing equivalents,
may block several metabolic enzymes (through allosteric
inhibition) and mitochondrial ETC proteins. The result is
an exacerbated overload affecting the kidney.
Taken together, PTC-specific ablation of CrAT causes
tubular injury, glomerulosclerosis, and kidney disease in
mice. We believe our results are in agreement with those
supporting the view that proximal tubular damage is also
a primary rather than just a secondary event in early DN.
The results are consistent with mitochondrial overload,
showing chronic effects in vivo: impaired nutrient utiliza-
tion, which is not limited to fatty acid oxidation (Fig. 7).
These results provide the basis for future studies to de-
cipher the acute effects and a potential protection from
overload. This can be achieved, for example, through
overexpressing CrAT in cultured tubular cells and then
challenging these cells to overload. In vivo, however, such
an approach might not provide additional protection in
case of an abundant metabolic enzyme like CrAT. Our
in vivo results point to a much broader approach to tackle
metabolic disease–associated tubular damage through im-
proving the mitochondrial energy balance. We propose
that disturbances in all three major metabolic pathways
(fatty acid, carbohydrate, and amino acid) can prime the
development of DN/CKD, primarily through alterations
in mitochondrial function, where lesions may occur first in
the tubules. Our findingsmay also have clinical implications:
provided that mitochondrial overload-induced mechanisms
are the forerunners of PTC apoptosis, targeting mitochon-
drial function and/or energy metabolism can emerge as
a new area considered for future interventions to effectively
prevent, rather than treat, tubular injury and CKD.
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